Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and...
markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 18, 2024 7:37pm
RE:RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
There are none. and for years the science has been proven over and over again as non commercial. Look at how many supposed companys looked at it. Of course we can't verify it a all it has been
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 6:14pm
RE:RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
example of Stonegate report on pre-revenue co...... https://stonegateinc.com/download/burcon-initiation/?wpdmdl=812&refresh=6630eb784e3821714482040
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 6:11pm
RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Stonegate issues research reports with financial anaylsis and price targets for other co.s....Sirona mgmt won't offer any damn visibility on revenues or earnings so Stonegate had to do a industry
...more
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 18, 2024 5:47pm
RE:IDIOT SELLING AT 5.5 CENTS!
Blame the present on past management. No friggin idiot is going to buy this based on some paid pump from some company that has been hired to pump it. Facts..As in real finacial reporting is going to
...more
(82)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jun 18, 2024 4:21pm
IDIOT SELLING AT 5.5 CENTS!
Some idiot sold at 5.5 cents, INSTANET! Hope they lost money on the sale. No patience to wait for more money and just doing psychological damage to the rest of the holders. We need at least
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 1:00pm
RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Pg. 26 - peptide column is new and it shows GPM has more benefits
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 11:54am
RE:News response
The full report: does not say SBM is a publicly traded co, does not provide a valuation on SBM, does not provide any timing other than GPM to lauch in 2025
(79)
•••
Pareto8020
X
View Profile
View Bullboard History
Post by
Pareto8020
on Jun 18, 2024 11:22am
News response
Seems to be a tepid response to the write-up with a paltry 40 shares traded so far. This is a "show me the money" stock now and until they do that it likely isn't going to see a
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 18, 2024 10:36am
New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare's newly published research report, "Novel Treatments...
read article.
(1806)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jun 18, 2024 9:55am
RE:Better bid this morning
Gee, looks like I was bang on! It is a good first step in getting the word out.
(37)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Jun 18, 2024 9:10am
$5,000/month
"Sirona is paying Stonegate Healthcare Partners $5,000/month for general consulting services"
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 9:05am
RE:New Press Release - Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations
"Just 3 years into its launch, OneSkin's OS-01 has already surpassed $100 million in sales."
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 18, 2024 8:52am
New Press Release - Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations
Dallas, Texas--(Newsfile Corp. - June 18, 2024) - Stonegate Healthcare Partners, a leading name in healthcare consultancy and market intelligence, is pleased to announce the publication of a comprehensive thematic report titled "Leading Innovations in Anti-Aging Dermatology." This report delves...
read article.
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 14, 2024 5:25pm
RE:RE:Better bid this morning
A quick flip of the stock to make some money on news. Pennies really. Some one knows some thing is coming and they want a double when this spikes on news. If it spikes at all and it won't be much
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >